Thursday, November 1, 2018
Weight Watchers sees FY18 EPS $3.15-$3.25, consensus $2.99
https://thefly.com/landingPageNews.php?id=2816098
Exelixis reports Q3 EPS 41c, consensus 19c
Exelixis reports Q3 EPS 41c, consensus 19c Reports Q3 revenue $225.4M, consensus $.
Pacira price target raised to $47 from $40 at BMO Capital
BMO Capital analyst Gary Nachman raised his price target on Pacira to $47 after its Q3 results topped consensus thanks to “solid Exparel growth and stronger gross margins”. The analyst also notes that the company raised its Exparel sales and gross margin guidance for 2018 along with some positive management commentary regarding its outlook heading into 2019. Nachman keeps his Market Perform rating on Pacira citing his sensitivity to the company’s valuation and the possibility of more competitive dynamics in the future.
https://thefly.com/landingPageNews.php?id=2816229
Tandem Diabetes rises after Medtronic FLAIR study said to be delayed
According to a post to ClinicalTrials.gov that was last updated on November 1, 2018, the Fuzzy Logic Automated Insulin Regulation, or FLAIR, study, which will investigate Medtronic’s (MDT) 670G hybrid closed loop system and advanced hybrid closed loop system in adolescents and young adults with type 1 diabetes, is estimated to start on March 30, 2019. According to an email from Craig-Hallum analyst Alexander Nowak, the trial was previously expected to start on September 1, 2018. Nowak has previously stated his belief that Tandem Diabetes (TNDM) is leading in terms of having the best automation and most discreet pump with Basal IQ, Control IQ launching within the next year and a 75% smaller pump than market leader Medtronic in the final stages of development. In afternoon trading, Tandem Diabetes shares are up $3.07, or 8.2%, to $40.68, while shares of another challenger in the space, Insulet (PODD), are up $2.47, or 2.8%, to $90.68.
Illumina to acquire Pacific Biosciences for $8 per share
https://thefly.com/landingPageNews.php?id=2815840
FDA panel votes 20-3 against effectiveness of Alkermes depression drug
https://thefly.com/landingPageNews.php?id=2815953
Subscribe to:
Posts (Atom)